ArticleCell reports2019

SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent Tumors.

Tamer A Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.